Ardelyx reported $441.39M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Amgen USD 34.36B 598M Sep/2026
Ardelyx USD 441.39M 538K Sep/2026
aTyr Pharma USD 50.16M 8.21M Sep/2026
Corcept Therapeutics USD 533.87M 94.2M Sep/2026
Curis USD 16.61M 9.7M Mar/2026
Sanofi EUR 31.52B 1.36B Jun/2026
TG Therapeutics USD 1.17B 25.76M Sep/2026
United Therapeutics USD 2.88B 603.5M Sep/2026